Polymeric core-shell nanoparticles for therapeutics

Clinical and Experimental Pharmacology and Physiology

Volumn 33, Issue 5-6, 2006, Pages 557-562

  Yang, Yi Yan ^a   Wang, Yong ^a   Powell, Ross ^a   Chan, Peggy ^a  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

Author keywords

Cationic polymer nanoparticles; Drug delivery; Gene delivery; Peptide protein delivery; Polymer core shell nanoparticles; Polymeric nanoparticles

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CETOMACROGOL; CGP 57813; CHITOSAN; CYCLOSPORIN A; CYTOTOXIC AGENT; DEXTRAN SULFATE; DOXORUBICIN; GELDANAMYCIN; IMMUNOSUPPRESSIVE AGENT; INSULIN; LIPOSOME; MACROGOL; NANOPARTICLE; POLY(BETA AMINO ESTER); POLY(METHACRYLIC ACID CO METHACRYLATE); POLY(N ISOPROPYLACRYLAMIDE); POLY(TRIMETHYLENE CARBONATE); POLYCAPROLACTONE; POLYGLACTIN; POLYHISTIDINE; POLYLACTIDE; POLYMER; PROTEIN DERIVATIVE; RACHELMYCIN; SALCATONIN; STEARIC ACID; TAXANE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL;

BIOCOMPATIBILITY; CANCER THERAPY; DIABETES MELLITUS; DRUG ACCUMULATION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG TARGETING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HYDROPHOBICITY; IMMUNOGENICITY; NANOTECHNOLOGY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; REVIEW; SOLID TUMOR;

ADMINISTRATION, ORAL; ANIMALS; DNA; DRUG CARRIERS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTESTINAL ABSORPTION; NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS, EXPERIMENTAL; POLYMERS; PROTEINS; RNA, SMALL INTERFERING; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 33745198929     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2006.04408.x     Document Type: Review

References (84)

1. The Royal Society, London. Nanoscience and Nanotechnology: Opportunities and Uncertainties Document. http://www.nanotech.org.uk/finalReport.htm (accessed October 2005).
2. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 2002 54 : 631 51.
3. Klibanov AL, Maruyama K, Torchilin VP, Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 1990 268 : 235 8.
4. Lasic DD, Martin FJ, Gabizon A, Huang SK, Papahadjopoulos D. Sterically stabilized liposomes: A hypothesis on the molecular origin of the extended circulation times. Biochim. Biophys. Acta 1991 1070 : 187 92.
5. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J. Control. Rel. 2000 65 : 271 84.
6. Kohler G, Milstein C. Continuous cultures of fuse cells secreting antibody of predefined specificity. Nature 1975 75 : 381 94.
7. Abou-Jawde R, Choueiri T, Alemany C, Mekhail T. An overview of targeted treatments in cancer. Clin. Ther. 2003 25 : 2121 37.
8. Torchilin VP, Levchenko TS, Lukyanov AN et al. p-Nitrophenylcarbonyl-PEG- PE-liposomes: Fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenyl carbonyl groups. Biochim. Biophys. Acta 2001 1511 : 397 411.
9. Shadidi M, Sioud M. Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells. FASEB J. 2003 17 : 256 8.
10. Dharap SS, Wang Y, Chandna P et al. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. Proc Natl Acad Sci USA 2005 102 : 12 62 7.
11. Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998 279 : 377 80.
12. Nishikawa M, Kamijo A, Fujta T, Takakura Y, Sezaki H, Hashida M. Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyl-dextran, and its application to drug targeting. Pharm. Res. 1993 10 : 1253 61.
13. Lee ES, Na K, Bae YH. Super pH-sensitive multifunctional polymeric micelle. Nano Lett. 2005 5 : 325 9.
14. Yoo HS, Park TG. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J. Control. Rel. 2004 100 : 247 56.
15. Schrama D, Reisfeld RA, Becker JC. Antibody targeted drugs as cancer therapeutics. Nat. Rev. Drug Discov. 2006 5 : 147 59.
16. Stohrer M, Boucher Y, Stangassinger M, Jain RK. Oncotic pressure in solid tumors is elevated. Cancer Res. 2000 60 : 4251 5.
17. Yokota T, Milenic DE, Whitlow M, Schlom J. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res. 1992 52 : 3402 8.
18. Hofmeister V, Vetter C, Schrama D, Bröcker EB, Becker JC. Tumor stroma-associated antigens for anti-cancer immunotherapy. Cancer Immunol. Immunother. 2006 55 : 481 94.
19. Langer R. Perspectives: Drug delivery: Drugs on target. Science 2001 293 : 58 9.
20. Chaw CS, Chooi KW, Liu XM, Tan CW, Wang L, Yang YY. Thermally responsive core-shell nanoparticles self-assembled from cholesteryl end-capped and grafted polyacrylamides: Drug incorporation and in vitro release. Biomaterials 2004 25 : 4297 308.
21. Liu SQ, Tong YW, Yang YY. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N- isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(d,l-lactide-co-glycolide) with varying compositions. Biomaterials 2005 26 : 5064 74.
22. Potineni A, Lynn DM, Langer R, Amiji MM. Poly(ethylene oxide)-modified poly(β-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery. J. Control. Rel. 2003 86 : 223 34.
23. Soppimath KS, Tan DCW, Yang YY. pH-Triggered thermally responsive polymer core-shell nanoparticles for drug delivery. Adv. Mater. 2005 17 : 318 23.
24. Zambaux MF, Bonneaux F, Gref R et al. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by double emulsion method. J. Control. Rel. 1998 50 : 31 40.
25. Dong Y, Feng SS. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005 26 : 6068 76.
26. Yoo HS, Park TG. Folate receptor targeted biodegradable polymeric doxorubicin micelles. J. Control. Rel. 2004 96 : 273 83.
27. Wei JS, Zeng HB, Liu SQ, Wang XG, Tay EH, Yang YY. Temperature- and pH-sensitive core-shell nanoparticles self-assembled from poly(N- isopropylacrylamide-co-acrylic acid-co-cholesteryl acrylate) for intracellular delivery of anticancer drugs. Front. Biosci. 2005 10 : 3058 67.
28. Kataoka K, Matsumoto T, Yokoyama M et al. Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-l-aspartate) copolymer micelles: Their pharmaceutical characteristics and biological significance. J. Control. Rel. 2000 64 : 143 53.
29. Zhang Y, Zhuo RX. Synthesis and in vitro drug release behavior of amphiphilic triblock copolymer nanoparticles based on poly(ethylene glycol) and polycaprolactone. Biomaterials 2005 26 : 6736 42.
30. Zhang Y, Zhuo RX. Synthesis and drug release behavior of poly(trimethylene carbonate)-poly(ethylene glycol)-poly(trimethylene carbonate) nanoparticles. Biomaterials 2005 26 : 2089 94.
31. Allen C, Maysinger D, Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf. B Biointerf. 1999 16 : 3 27.
32. Wong HL, Bendayan R, Rauth AM, Wu XY. Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers. J. Pharm. Sci. 2004 93 : 1993 2008.
33. Borghouts C, Kunz C, Groner B. Current strategies for the development of peptide-based anti-cancer therapeutics. J. Pept. Sci. 2005 11 : 713 26.
34. Pavlou AK, Reichert JM. Recombinant protein therapeutcs: Success rates, market trends and values to 2010. Nat. Biotechnol. 2004 22 : 1513 19.
35. Kompella UB, Lee VHL. Pharmacokinetics of peptide and Protein drugs. In : Lee VHL (ed.). Peptide and Protein Drug Delivery. Marcel Dekker, New York. 1991 391 484.
36. Rabkin R, Dahl DC. Renal uptake and disposal of proteins and peptides. In : Audus KL, Raub TJ (eds). Biological Barriers in Protein Delivery. Plenum Press, New York. 1993 299 338.
37. Zhang Q, Yie G, Li Y, Yang Q, Nagai T. Studies on the cyclosporin A loaded stearic acid nanoparticles. Int. J. Pharm. 2000 200 : 153 9.
38. De Campos AM, Sanchez A, Alonso MJ. Chitosan nanoparticles. A new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int. J. Pharm. 2001 224 : 159 68.
39. Dai J, Nagai T, Wang X, Zhang T, Meng M, Zhang Q. pH-Sensitive nanoparticles for improving the oral bioavailability of cyclosporine A. Int. J. Pharm. 2004 280 : 229 40.
40. Francis MF, Cristea M, Yang Y, Winnik FM. Engineering polysaccharide-based polymeric micelles to enhance permeability of cyclosporin A across Caco-2 cells. Pharm. Res. 2005 22 : 209 19.
41. Aliabadi HM, Brocks DR, Lavasanifar A. Polymeric micelles for the solubilization and delivery of cyclosporine A: Pharmacokinetics and biodistribution. Biomaterials 2005 26 : 7251 9.
42. Low PJ, Temple CS. Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: Protection against proteases and effect on intestinal absorption in rats. J. Pharm. Pharmacol. 1994 46 : 547 52.
43. Carino GP, Jacob JS, Mathiowitz E. Nanosphere based oral insulin delivery. J. Control. Rel. 2000 65 : 261 9.
44. Simon M, Wittmar M, Bakowsky U, Kissel T. Self-assembling nanocomplexes from insulin and water-soluble branched polyesters, poly[(vinyl-3-(diethylamino) -propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft-poly(l-lactic acid): A novel carrier for transmucosal delivery of peptides. Bioconjug. Chem. 2004 15 : 841 9.
45. Ma Z, Lim TM, Lim LY. Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats. Int. J. Pharm. 2005 293 : 271 80.
46. Mesiha MS, Sidhom MB, Fasipe B. Oral and subcutaneous absorption of insulin poly(isobutylcyanoacrylate) nanoparticles. Int. J. Pharm. 2005 288 : 289 93.
47. Leroux JC, Cozens R, Roesel JL et al. Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice. J. Pharm. Sci. 1995 84 : 1387 91.
48. Yoo HS, Park TG. Biodegradable nanoparticles containing protein-fatty acid complexes for oral delivery of salmon calcitonin. J. Pharm. Sci. 2004 93 : 488 95.
49. Garcia-Fuentes M, Prego C, Torres D, Alonso MJ. A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery. Eur. J. Pharm. Sci. 2005 25 : 133 43.
50. Fraley R, Subramani S, Berg P, Papahadjopoulos D. Introduction of liposome-encapsulated SV40 DNA into cells. J. Biol. Chem. 1980 255 : 10 31 5.
51. Smisterová J, Wagenaar A, Stuart MCA et al. Molecular shape of the cationic lipid controls the structure of cationic lipid/ dioleylphosphatidylethanolamine-DNA complexes and the efficiency of gene delivery. J. Biol. Chem. 2001 276 : 47 15 22.
52. Kakizawa Y, Kataoka K. Block copolymer micelles for delivery of gene and related compounds. Adv. Drug Deliv. Rev. 2002 54 : 203 22.
53. Gemeinhart RA, Luo D, Saltzman WM. Cellular fate of a modular DNA delivery system mediated by silica nanoparticles. Biotechnol. Prog. 2005 21 : 532 7.
54. Singh R, Pantarotto D, McCarthy D et al. Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: Toward the construction of nanotube-based gene delivery vectors. J. Am. Chem. Soc. 2005 127 : 4388 96.
55. Salem AK, Searson PC, Leong KW. Multifunctional nanorods for gene delivery. Nat. Mater. 2003 2 : 668 71.
56. Coll JL, Chollet P, Brambilla E, Desplanques D, Behr JP, Favorot M. In vivo delivery to tumors of DNA complexed with linear polyethylenimine. Hum. Gene Ther. 1999 10 : 1659 66.
57. Kleemann E, Dailey LA, Abdelhady HG et al. Modified polyethylenimines as non-viral gene delivery systems for aerosol gene therapy: Investigations of the complex structure and stability during air-jet and ultrasonic nebulization. J. Control. Rel. 2004 100 : 437 50.
58. Fajac I, Allo JC, Souil E et al. Histidylated polylysine as a synthetic vector for gene transfer into immortalized cystic fibrosis airway surface and airway gland serous cells. J. Gene Med. 2000 2 : 368 78.
59. Benns JM, Choi JS, Mahato RI, Park JS, Kim SW. pH-Sensitive cationic polymer gene delivery vehicle: N-Ac-poly(l-histidine)-graft-poly(l-lysine) comb shaped polymer. Bioconjug. Chem. 2000 11 : 637 45.
60. Koping-Hoggard M, Tubulekas I, Guan H et al. Chitosan as a non-viral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther. 2001 8 : 1108 21.
61. Tang MX, Redemann CT, Szoka FCJ. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug. Chem. 1996 7 : 703 14.
62. Marschall P, Malik N, Larin Z. Transfer of YACs up to 2.3 Mb intact into human cells with polyethylenimine. Gene Ther. 1999 6 : 1634 7.
63. Campeau P, Chapdelaine P, Seigneurin-Vemin S, Massie B, Tremblay JP. Transfection of large plasmids in primary human myoblasts. Gene Ther. 2001 8 : 1387 94.
64. Godbey WT, Wu KK, Hirasaki GJ, Mikos AG. Improved packing of polyethylenimine/DNA complexes increases transfection efficiency. Gene Ther. 1999 6 : 1380 8.
65. Boussif O, Lezoualc'h F, Zanta MA et al. A versatile vector for gene and ologomucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl Acad. Sci. USA 1995 92 : 7297 301.
66. Mumper RJ, Duguid JG, Anwer K, Barron MK, Nitta H, Rolland AP. Polyvinyl deirviatives as novel interactive polymers for controlled gene delivery to muscle. Pharm. Res. 1996 13 : 701 9.
67. Leong KW, Mao HQ, Truong-Le VL, Roy K, Walsh SM, August JT. DNA-polycation nanospheres as non-viral gene delivery vehicles. J. Control. Rel 1998 53 : 183 93.
68. Isobe H, Sugiyama S, Fukui K, Iwasawa Y, Nakamura E. Atomic force microscope studies on condensation of plasmid DNA with functionalized fullerenes. Angews Chem. Int. Ed. 2001 40 : 3364 7.
69. Wang J, Zhang PC, Lu HF et al. New polyphophoramidate with a spermidine side chain as a gene carrier. J. Control. Rel. 2002 83 : 157 68.
70. Azzam T, Eliyahu H, Shapira L, Linial M, Barenholz Y, Domb AJ. Polysaccharide-oligoamine based conjugates for gene delivery. J. Med. Chem. 2002 45 : 1817 24.
71. Popielarski SR, Mishra S, Davis ME. Structural effects of carbohydrate-containing polycations on gene delivery: 3. Cyclodextrin type and functionalization. Bioconjug. Chem. 2003 14 : 672 8.
72. Mao HQ, Roy K, Troung-Le VL et al. Chitosan-DNA nanoparticles as gene carriers: Synthesis, characterization and transfection efficiency. J. Control. Rel. 2001 70 : 399 421.
73. Lee H, Leong JH, Park TG. A new gene delivery formulation of polyethylenimine-DNA complexes coated with PEG conjugated fusogenic peptide. J. Control. Rel. 2001 76 : 183 92.
74. Mesika A, Kiss V, Brumfeld V, Ghosh G, Reich Z. Enhanced intracellular mobility and nuclear accumulation of DNA plasmids associated with a karyophilic protein. Hum. Gene Ther. 2005 16 : 200 8.
75. Ogris M, Walker G, Blessing T, Kircheis R, Wolschek M, Wagner E. Tumor-targeted gene therapy: Strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J. Control. Rel. 2003 91 : 173 81.
76. Sagara K, Kim SW. A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes. J. Control. Rel. 2002 79 : 271 81.
77. Cho KC, Jeong JH, Chung HJ, Joe CO, Kim SW, Park TG. Folate receptor-mediated intracellular delivery of recombinant caspase-3 for inducing apoptosis. J. Control. Rel. 2005 108 : 121 31.
78. Xia H, Mao Q, Paulson HL, Davidson BL. SiRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol. 2002 20 : 1006 10.
79. Devroe E, Silver PA. Therapeutic potential of retroviral RNAi vectors. Expert Opin. Biol. Ther. 2004 4 : 319 27.
80. Landen CN Jr., Chavez-Reyes A, Bucana C et al. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res. 2005 65 : 6910 18.
81. Schiffelers RM, Ansari A, Xu J et al. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res. 2004 32 : E149.
82. Kakizawa Y, Furukawa S, Kataoka K. Block copolymer-coated calcium phosphate nanoparticles sensing intracellular environment for oligodeoxynucleotide and siRNA delivery. J. Control. Rel. 2004 97 : 345 56.
83. Itaka K, Kanayama N, Nishiyama N et al. Supramolecular nanocarrier of siRNA from PEG-based block catiomer carrying diamine side chain with distinctive pKa directed to enhance intracellular gene silencing. J. Am. Chem. Soc. 2004 126 : 13 12 13.
84. Tan PH, Beutelspacher SC, Wang YH et al. Immunolipoplexes: An efficient, nonviral alternative for transfection of human dendritic cells with potential for clinical vaccination. Mol. Ther. 2005 11 : 790 800.